Pharmacia & Upjohn Company

Erik Ho Fong Wong

Philip F Von Voigtlander

John M McCall

Duncan Paul Taylor

Fred Hassan

Robert Clyde Marshall

Torgny Svensson

Christopher C Gallen

Adriana Dubini

Combinations of reboxetine and neuroleptic agents

This patent application describes the treatment of Addictive disorders, Psychoactive Substance Use disorders, Intoxication disorders, Inhalation disorders, Alcohol addiction, Tobacco addiction and or Nicotine addiction; and Attention Deficit Hyperactivity Disorder (ADHD); comprising administering a therapeutically effective, nontoxic dose of Reboxetine and derivatives and or pharmaceutically acceptable salts thereof to a patient.

Treatments for nervous disorders

This patent application describes the treatment addictive disorders, psychoactive substance use disorders, intoxication disorders, inhalation disorders, alcohol addiction, tobacco addiction and or nicotine addiction comprising administering a therapeutically effective, nontoxic dose of pramipexole and derivatives and or pharmaceutically acceptable salts thereof to a patient.

Use of pramipexole for the treatment of addictive disorders

This invention relates to the use of reboxetine in the treatment of Obsessive Compulsive Disorders and Panic Disorders.

Reboxetine for treatment obsessive compulsive disorders and panic disorder

This patent application describes the treatment of Addictive Disorders, Psychoactive Substance Use Disorders, Intoxication disorders, Inhalation disorders, Alcohol addiction, Tobacco Addiction and or Nicotine Addiction; and Attention Deficit Hyperactivity Disorder (ADHD); comprising administering a therapeutically effective, nontoxic dose of Reboxetine and derivatives and or pharmaceutically acceptable salts thereof to a patient.

Growing community of inventors

Portage, MI, United States of America

Erik Ho Fong Wong